Suppr超能文献

人 CADASIL 血管平滑肌细胞中的自噬溶酶体缺陷。

Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells.

机构信息

Division of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Huddinge, Sweden.

Medicum, Biochemistry/Developmental Biology, Meilahti Clinical Proteomics Core Facility, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, Finland.

出版信息

Eur J Cell Biol. 2018 Nov;97(8):557-567. doi: 10.1016/j.ejcb.2018.10.001. Epub 2018 Oct 22.

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a familial progressive degenerative disorder and is caused by mutations in NOTCH3 gene. Previous study reported that mutant NOTCH3 is more prone to form aggregates than wild-type NOTCH3 and the mutant aggregates are resistant to degradation. We hypothesized that aggregation or accumulation of NOTCH3 could be due to impaired lysosomal-autophagy machinery in VSMC. Here, we investigated the possible cause of accumulation/aggregation of NOTCH3 in CADASIL using cerebral VSMCs derived from control and CADASIL patients carrying NOTCH3 mutation. Thioflavin-S-staining confirmed the increased accumulation of aggregated NOTCH3 in VSMC compared to VSMC. Increased levels of the lysosomal marker, Lamp2, were detected in VSMC, which also showed co-localization with NOTCH3 using double-immunohistochemistry. Increased level of LC3-II/LC3-I ratio was observed in VSMC suggesting an accumulation of autophagosomes. This was coupled with the decreased co-localization of NOTCH3 with LC3, and Lamp2 and, further, increase of p62/SQSTM1 levels in VSMC compared to the VSMC. In addition, Western blot analysis indicated phosphorylation of p-ERK, p-S6RP, and p-P70 S6K. Altogether, these results suggested a dysfunction in the autophagy-lysosomal pathway in VSMC. The present study provides an interesting avenue of the research investigating the molecular mechanism of CADASIL.

摘要

伴有皮质下梗死和白质脑病的常染色体显性脑动脉病(CADASIL)是一种家族性进行性退行性疾病,由 NOTCH3 基因突变引起。以前的研究表明,突变型 NOTCH3 比野生型 NOTCH3 更容易形成聚集体,并且突变型聚集体不易降解。我们假设 NOTCH3 的聚集或积累可能是由于血管平滑肌细胞中溶酶体-自噬机制受损所致。在这里,我们使用源自携带 NOTCH3 突变的对照和 CADASIL 患者的脑血管平滑肌细胞,研究了 CADASIL 中 NOTCH3 积累/聚集的可能原因。硫黄素 S 染色证实与血管平滑肌细胞相比,NOTCH3 聚集物在血管平滑肌细胞中的积累增加。在血管平滑肌细胞中检测到溶酶体标志物 Lamp2 的水平升高,并且使用双重免疫组织化学也显示与 NOTCH3 共定位。在血管平滑肌细胞中观察到 LC3-II/LC3-I 比值增加,表明自噬体的积累。这与 NOTCH3 与 LC3、Lamp2 的共定位减少有关,并且与血管平滑肌细胞相比,p62/SQSTM1 水平增加。此外,Western blot 分析表明 p-ERK、p-S6RP 和 p-P70 S6K 的磷酸化。总之,这些结果表明血管平滑肌细胞中的自噬溶酶体途径功能障碍。本研究为研究 CADASIL 的分子机制提供了一个有趣的研究途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验